Summary:
Click image to enlargeThis trial will look at an investigational fast-acting insulin to see if it works as effectively as an existing fast-acting insulin already being used to treat diabetes.
Qualified Participants Must:
• Be 18 to 65 years old
•
Have been diagnosed with type 1 diabetes for at least six months
•
Are on a stable once daily dose of basal Lantus or Toujeo injections and multiple daily bolus NovoLog injections for at least 3 months prior to screening
•
Have not used insulin pump therapy or any anti-diabetic medications other than trial-approved insulins within the last 3 months
•
Have not used animal insulin (such as from a cow or pig) within the last 2 years
•
Have not used a regular immunomodulator therapy within the last year
•
Able and willing to self-monitor blood glucose, including up to 7 times per day on selected days
Qualified Participants May Receive:
- Trial-related medications, procedures, equipment and supplies will be provided at no cost
- Compensation for time and travel